Demystifying human-centred design: the application of iterative, human-centric approaches in global health market research
One of the biggest buzz topics in the global health community over the last couple of years has been human-centred design, also referred to as behavior-centred design. In this blog I outline our understanding of a) human-centred design, b) how it can be applied to improve global health interventions, and c) how it intersects with market research.
In the news: What will the UK’s recent general election result and ongoing Brexit negotiations mean for DfID funding for global health?
The UK’s Department for International Development (DfID) was established in 1997 with a mandate to tackle world poverty. Since its inception, it has played a major role in the global health landscape through bilateral programs, health partnerships, and the support of multilateral organisations, as well as influencing global health policy and international health research. Its future has come under increasing scrutiny following the UK referendum result in favour of leaving the EU last year, and again in the wake of last month’s general election result.
Online Community Research – What to consider when running an online research community?
The use of online communities is becoming more common in healthcare market research. Online community research means creating an intentionally established platform to bring together a group of like-minded individuals who take part in guided discussions and structured exercises about a specified topic. As technology continues to improve, online platforms have become increasingly more interactive and user friendly. As I’m currently working on an online platform, I was intrigued to find out more about this method of research; why should we be using online communities in healthcare market research?
Healthcare Market Research in the Gulf: 3 lessons I’ve learned
A few key considerations for conducting healthcare market research in the Gulf
Something I recently discovered whilst working on an emerging markets project is that conducting healthcare market research in the Gulf is very different to conducting research in western countries. Whilst the Gulf region is not one single, homogenous market, there are three general truths I learned which I’d like to share
A bitter pill?
The ideal route of admin isn’t clear cut in the global marketplace
A key feature of any pharmaceutical product is its route of administration; the path through which the drug is taken into the body. This may be oral, injectable, transdermal or inhaled. Differences in route of admin can be critical points of differentiation for new pharmaceutical products, especially in crowded markets where multiple options are available. When conducting interviews with healthcare professionals, we commonly find that route of admin is often one of the first features they take into account (after efficacy and safety) when reviewing product profiles, and getting it right is fundamental to a product’s eventual uptake and market share. However the perceived benefits and drawbacks of different routes of administration can be more complicated than one might think. Market nuances can have far-reaching implications for drug formulation and device design.